Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3428]

Can early stage NSCLC be treated with stereotactic radiation therapy?

Dr David Palma – London Health Sciences Centre, London, Canada

Can early stage NSCLC be treated with stereotactic radiation therapy? ( Dr David Palma – London Health Sciences Centre, London, Canada )

Treatment strategies and options in castration-resistant and advanced prostate...

Prof Peter Mulders, Prof Luis Costa, Prof Antonio Alcaraz, Prof Anwar Padhani

Treatment strategies and options in castration-resistant and advanced prostate cancer ( Prof Peter Mulders, Prof Luis Costa, Prof Antonio Alcaraz, Prof Anwar Padhani )

What are the obstacles in cancer prevention?

Prof Jack Cuzick - Queen Mary University of London, London, UK

What are the obstacles in cancer prevention? ( Prof Jack Cuzick - Queen Mary University of London, London, UK )

Epigenetics in cancer genesis

Dr Manel Esteller – Instituto de Investigación Biomédica de Bellvitge...

Epigenetics in cancer genesis ( Dr Manel Esteller – Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain )

What is the potential for using monoclonal antibodies in multiple myeloma?

Prof Sagar Lonial, Prof Pieter Sonneveld, Prof Jesús San Miguel

What is the potential for using monoclonal antibodies in multiple myeloma? ( Prof Sagar Lonial, Prof Pieter Sonneveld, Prof Jesús San Miguel )

Expert discussion on current experience with monoclonal antibodies in multiple...

Prof Antonio Palumbo and Prof Philippe Moreau

Expert discussion on current experience with monoclonal antibodies in multiple myeloma ( Prof Antonio Palumbo and Prof Philippe Moreau )

ECC 2015: Editor's highlights

Prof Gordon McVie - ecancer Managing Editor

ECC 2015: Editor's highlights ( Prof Gordon McVie - ecancer Managing Editor )

ecancermedicalscience editor's choice for September 2015

Prof Gordon McVie - ecancer Managing Editor

ecancermedicalscience editor's choice for September 2015 ( Prof Gordon McVie - ecancer Managing Editor )

First ‘targeted’ treatment for small cell lung cancer shows promise

Dr Catherine Pietanza - Memorial Sloan Cancer Center, New York, USA

First ‘targeted’ treatment for small cell lung cancer shows promise ( Dr Catherine Pietanza - Memorial Sloan Cancer Center, New York, USA )

Is it possible to develop cancer drugs at a lower cost?

Prof Andrew Hill - University of Liverpool, Liverpool, UK

Is it possible to develop cancer drugs at a lower cost? ( Prof Andrew Hill - University of Liverpool, Liverpool, UK )

Expanding access to crizotinib using a biomarker-driven approach

Prof Gilles Vassal - University Paris-Sud, Orsay, France

Expanding access to crizotinib using a biomarker-driven approach ( Prof Gilles Vassal - University Paris-Sud, Orsay, France )

Multi-peptide vaccine for kidney cancer fails to improve survival

Dr Brian Rini - Cleveland Clinic Foundation, Cleveland, USA

Multi-peptide vaccine for kidney cancer fails to improve survival ( Dr Brian Rini - Cleveland Clinic Foundation, Cleveland, USA )

More from ecancer